N
CLPT icon

Numerai’s ClearPoint Neuro CLPT Stock Holding History

Numerai’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379K Buy
+41,689
New +$526K 0.04% 590

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Numerai's CLPT Position: Q1 2026 in Review

Numerai opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 41,689 shares worth $379K. The stake represents 0.04% of the portfolio and ranks #590 among its holdings.

118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Numerai held 41,689 shares of ClearPoint Neuro worth $379K as of Q1 2026.
  • ClearPoint Neuro was a new Numerai position in Q1 2026.
  • ClearPoint Neuro made up 0.04% of Numerai's portfolio in Q1 2026, its #590 holding.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.